City

Bethesda (1)

Condition

Breast Cancer (1)

HER2+ Breast Cancer (1)

Hormone Receptor Negative Breast Cancer (1)

Metastatic Breast Cancer (1)

Triple Negative Breast Cancer (1)

Overall Status

Terminated (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

National Cancer Institute (NCI) (1)

Collaborator

Intervention

ado-trastuzumab emtansine (1)

brachyury-tricom (1)

entinostat (1)

m7824 (1)

Study Documents

Intervention Type

biological (1)

drug (1)

Funder Type

NIH (1)

Study Type

Interventional (1)

hormone receptor negative breast cancer

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Breast Cancer, Triple Negative Breast Cancer, HER2+ Breast Cancer Trial run by the NCI (Brachyury-TRICOM, Entinostat, M7824)

Terminated

Breast Cancer
+4 more

Brachyury-TRICOM
+3 more

Bethesda, Maryland

National Institutes of Health Clinical Center

Dec 9, 2021